A key Food and Drug Administration advisory committee on Thursday unanimously recommended giving booster shots of Moderna's Covid-19 vaccine to people ages 65 and older and other vulnerable Americans.
FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.
WASHINGTON (AP) — The Food and Drug Administration said Wednesday it has expanded existing warnings on the two leading COVID-19 vaccines about a rare heart side effect mainly seen in young men.
A Food and Drug Administration (FDA) advisory panel voted 18-0 to authorize a Pfizer booster shot for Americans 65 years and older and those at risk of severe COVID-19 infection. The panel also voted ...
COVID booster vaccinations reduced the likelihood of hospitalization related to COVID in patients with autoimmune diseases, with monovalent and bivalent booster vaccines showing 38% and 32% ...
Healthy Americans under 65 who want an annual COVID vaccine will be out of luck under a new Food and Drug Administration policy unveiled Tuesday. Under the plan, the FDA will allow seniors and other ...
FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.
The FDA will require clinical trails for annual COVID-19 booster approval for healthy Americans under 65. Boosters will remain available for those over 65 and people with certain health conditions.
Covid vaccines continue to protect against serious illness and death, especially for people ages 65 and older, although the benefits for younger adults are not as clear, according to a large new study ...
In what has become a pattern of spreading vaccine misinformation, the Florida health department is telling older Floridians and others at highest risk from COVID-19 to avoid most booster shots, saying ...
The Centers for Disease Control and Prevention (CDC) has endorsed a plan to "allow" people over age 65 and those who are immunocompromised to get a second dose of the COVID-19 bivalent booster. This ...